P1.16-49 Treatment of NSCLC Patients With Clinical N1 Disease: Is There an Advantage to Neoadjuvant Therapy?
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1018
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV